Discuss lesions of breast in children and adolescents

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Searching PubMed

breast lesions children adolescents benign

Reading Article
Reading Article
I now have comprehensive information to write a thorough, well-structured answer. Let me compose it.

Lesions of the Breast in Children and Adolescents

Breast lesions in the pediatric and adolescent age group are uncommon, but when they do occur, the vast majority (>95%) are benign. Breast cancer in this age group is extremely rare. Management principles differ substantially from adults, and a conservative, observation-based approach is preferred in most situations to protect the developing breast bud.

Normal Breast Development - Context

Before puberty, the breast consists primarily of dense fibrous stroma and scattered ducts. Puberty begins between ages 9-12 years (United States data), with breast development (thelarche) serving as the earliest sign of puberty in girls. Menarche typically follows at ages 11-14. Breast bud development (Tanner stage 2) corresponds to the appearance of a subareolar mound - this must not be confused with a pathological mass and must never be excised.
  • Sabiston Textbook of Surgery, p. 1372

Classification of Breast Lesions in Children and Adolescents

1. Developmental Anomalies

These arise from aberrant embryological development of the milk streak (mammary ridge), which normally extends from the axilla to the inguinal area.
AnomalyDescription
PolymastiaAccessory breast tissue, commonly in the axilla; may enlarge during pregnancy
PolytheliaAccessory nipple(s) along the milk line
Amastia/AtheliaAbsence of breast tissue or nipple; rare
Poland syndromeUnilateral loss of breast tissue + pectoralis major/minor + serratus anterior + ribs
Adolescent asymmetryUnilateral hypertrophy of one breast vs the other; common variant
Accessory breast tissue located in the axilla can present as an enlarging mass during pregnancy and may persist after lactation. These conditions are typically managed conservatively until breast development is complete.
  • Sabiston Textbook of Surgery, p. 1372

2. Aberrations of Normal Development and Involution (ANDI Framework)

The ANDI framework classifies benign breast disorders as exaggerations of normal physiological changes. During the early reproductive period (ages 15-25), lobule and stromal formation occurs. Corresponding ANDI conditions are:
  • Fibroadenoma - the commonest breast mass
  • Juvenile hypertrophy - excessive breast development
When these progress to a disease state, the result is giant fibroadenoma or multiple fibroadenomas.
  • Berek & Novak's Gynecology, p. 979-980

3. Fibroadenoma (Most Common Breast Lesion)

Fibroadenomas account for approximately 95% of all breast lesions in children and adolescents (Sosnowska-Sienkiewicz et al., 2024, PMID: 39507494).
Epidemiology: Most common in women aged 15-35 years; more common than cysts in women under 25. They are estrogen-responsive and rarely occur after menopause.
Clinical features:
  • Firm, smooth, rubbery, freely mobile mass - often described as a "breast mouse"
  • No inflammatory reaction, no skin dimpling, no nipple retraction
  • Often bilobed (a groove can be palpated)
  • Usually 1-3 cm when detected
Imaging: On ultrasound, a well-defined, smooth, oblong solid mass with clearly defined margins. Mammography shows similar features.
Natural history: About 15% regress spontaneously; 75-80% remain static at 2-3 cm; only 5-10% progress in size.
Management:
  • Classic imaging appearance in a young patient - does not require biopsy; observe with short-interval ultrasound
  • Asymptomatic, stable lesions - conservative observation
  • Growing or symptomatic lesions - excision to rule out phyllodes tumor or carcinoma
  • Fibroadenoma is not associated with increased breast cancer risk
  • Berek & Novak's Gynecology, pp. 984-985; Mulholland & Greenfield's Surgery, p. 3903

Giant Fibroadenoma

  • Defined as >10 cm in size
  • Surgical excision recommended - difficult to distinguish from phyllodes tumor
  • Mulholland & Greenfield's Surgery, p. 3904

Juvenile (Cellular) Fibroadenoma

  • Occurs in young women aged 10-18 years
  • Can range from 5-20 cm in diameter
  • Rapid growth is characteristic
  • Surgical excision is recommended - cosmetically distressing and difficult to differentiate from phyllodes tumor
  • Important caveat: risk of damage to the prepubertal breast bud is a recognized complication of surgery
  • Mulholland & Greenfield's Surgery, p. 3904

Complex Fibroadenoma

  • Associated with proliferative changes: sclerosing adenosis, ductal epithelial hyperplasia, epithelial calcification, or papillary apocrine changes
  • Surgical excision often recommended to exclude carcinoma

4. Phyllodes Tumor

Epidemiology: Rare fibroepithelial tumor; more common in women aged 30s-50s, but can occur in adolescents. Usually presents as an isolated mass clinically indistinguishable from a fibroadenoma.
Behavior spectrum:
  • Benign: 60%
  • Borderline: 20%
  • Malignant: 20%
Clinical clue: Patient often relates a long history of a previously stable nodule that suddenly increases in size - this distinguishes it from the typical slow-growing fibroadenoma.
Management: Surgical excision with wide clear margins. Wide local excision is recommended even for benign lesions due to high local recurrence rates. Malignant phyllodes may require mastectomy.
  • Berek & Novak's Gynecology, p. 985

5. Juvenile (Virginal) Hypertrophy - Macromastia

  • Excessive breast growth during puberty, typically bilateral
  • Can cause significant physical symptoms: neck, shoulder, and back pain
  • Postural disturbances including forward shoulder posture and compensatory trapezius hypertrophy
  • Shoulder grooving from support garments
  • Primary therapy: weight management if obesity is a contributing factor
  • Definitive treatment: reduction mammoplasty (94% improvement in shoulder grooving, 88% improvement in self-esteem reported postoperatively)
  • Berek & Novak's Gynecology, pp. 991-992

6. Inflammatory/Infectious Lesions

Neonatal/Breast Abscess

  • Neonatal breast secretion ("witch's milk") occurs in ~90% of newborns due to elevated maternal hormones
  • If the secretion sequesters, it can cause a lactocele or mass that usually resolves within 3-4 weeks
  • Staphylococcal mastitis or abscess can occur in neonates - requires antibiotics and surgical drainage if fluctuant

Periductal Mastitis

  • Can occur in young women and adolescents
  • Associated with nipple discharge and subareolar inflammation
  • Sabiston Textbook of Surgery, p. 1372

7. Cystic Lesions

  • Simple cysts are uncommon in adolescents (more common in mature reproductive-age women)
  • Pubertal retroareolar cysts - a distinct entity presenting as bluish subareolar lumps at puberty; recently reviewed in pediatric literature (Guido et al., 2024, PMID: 38712575)
  • Fibrocystic change is an ANDI condition of the mature reproductive period and is less relevant in this age group

8. Proliferative Lesions

These are rare in children and adolescents but may be encountered:
  • Ductal hyperplasia - incidental finding; benign cells with increased numbers; no significant cancer risk; no additional treatment needed
  • Intraductal papilloma - presents with pathologic (often bloody) nipple discharge; surgical excision recommended when diagnosed on core needle biopsy due to risk of atypia or DCIS
  • Sclerosing adenosis - benign lobular lesion; no further treatment after biopsy
  • Mulholland & Greenfield's Surgery, pp. 3902-3903

9. Malignant Breast Lesions

Breast cancer in patients under 18 years is extremely rare. When it does occur, the most common primary breast malignancy in children is secretory (juvenile) carcinoma, which has a relatively favorable prognosis. Secondary/metastatic involvement (e.g., from lymphoma, rhabdomyosarcoma, neuroblastoma) is more common than primary breast cancer in very young patients.
Key points:
  • Invasive diagnostic testing and aggressive management are only recommended when clinical suspicion of malignancy is very high
  • A multidisciplinary team approach is essential (pediatric oncologist, surgeon, radiation oncologist, pathologist)
  • Prior chest radiation (e.g., for childhood lymphoma) is a known risk factor for subsequent breast cancer

Diagnostic Approach

History and Examination

  • Age, pubertal status, menstrual history
  • Duration, rate of growth, associated symptoms (pain, discharge)
  • Family history of breast cancer
  • Physical examination of breast and axillary lymph nodes

Imaging

  • Ultrasound is the first-line and most commonly used imaging modality in this age group (avoids radiation, superior for dense breast tissue)
  • Mammography: rarely indicated; used in cases of diagnostic doubt
  • MRI: reserved for complex clinical scenarios

Biopsy

  • Core needle biopsy (CNB): preferred when tissue diagnosis is needed
  • Excisional biopsy: for complex or indeterminate lesions
  • Fine needle aspiration cytology (FNAC) has a role but lower diagnostic yield than CNB

Management Summary

LesionManagement
Fibroadenoma (simple, <3 cm, stable)Conservative - observation + serial ultrasound every 6-12 months
Fibroadenoma (growing, symptomatic)Excision
Juvenile fibroadenoma (5-20 cm)Excision (caution: protect breast bud)
Giant fibroadenoma (>10 cm)Excision
Phyllodes tumorWide local excision with clear margins
Juvenile hypertrophyReduction mammoplasty when conservative measures fail
CystsAspiration or observation
Malignant lesionMultidisciplinary management
Key principle: Conservative observation is the cornerstone of managing most benign breast lesions in children and adolescents. Unnecessary biopsy or excision risks damage to the developing breast bud.

Recent Evidence

Two current reviews from 2023-2024 confirm these management principles:
  • Sosnowska-Sienkiewicz P et al. (2024) - Front Pediatr - comprehensive scoping review; fibroadenomas comprise 95% of lesions; recommends conservative approach with periodic ultrasound every 6-12 months; CNB preferred over excisional biopsy in most cases [PMID: 39507494]
  • Mubarak F et al. (2023) - Curr Probl Pediatr Adolesc Health Care - emphasizes that differentiation between fibroadenoma and phyllodes tumor guides management; aggressive work-up only when malignancy is strongly suspected [PMID: 37914550]
  • Schwartz D et al. (2025) - APSA Cancer Committee expert consensus recommendations for managing pediatric breast masses [PMID: 39384492]
This is a shared conversation. Sign in to Orris to start your own chat.